SCHEMBL5637099

SCHEMBL5637099

N#C/C(=C\c1c(-c2ccc(-c3ccccc3)c(F)c2)[nH]c2ccccc12)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ LMNA P02545 2/20 0.43
▸ PKM P14618 4/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ PTGS2 P35354 5/20 0.39
▸ POLB P06746 3/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ALPG P10696 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ PIK3CA P42336 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5637102 1.00 MAPT (0.51) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636055 0.88 KMT2A (0.49) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636050 0.88 KMT2A (0.49) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5635333 0.87 MAPT (0.62) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636618 0.86 MAPT (0.56) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636621 0.86 MAPT (0.56) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636258 0.86 MAPT (0.60) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636256 0.86 MAPT (0.60) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636005 0.82 ALDH1A1 (0.58) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL5636002 0.82 ALDH1A1 (0.58) MAPTKMT2AMEN1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 — — US claimed
US-20070010559-A1 Indole derivatives for use as chemical uncoupler NOVO NORDISK A/S (DK) 2007-01-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010559-A1 Indole derivatives for use as chemical uncoupler GPR119, IDO2, IDO1 MAPT 4316/4885KMT2A 1438/4885MEN1 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback